Universal Rare Gene Study: A Registry and Natural History Study of Retinal Dystrophies Associated with Rare Disease-Causing Genetic Variants
Karo Barsamian
WANDA MARTINEZ NAMED 2023 DISTINGUISHED ALUMNA
We are pleased to announce that Wanda Martinez, MD, PhD is the recipient of the 2023 Ophthalmology Alumni Association’s Distinguished Alumni Award.
Best Wishes to Our 2023 Graduates!
Congratulations to our residency and fellowship graduates! With a dedication to excellence and a commitment to patient care, we are confident they will go on to make significant contributions to the field of ophthalmology.
SANDCAT
A Phase III, Multicenter, Randomized, Double-Masked, Sham-Controlled Study to Investigate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of RO7200220 Administered Intravitreally in Patients with Uveitic Macular Edema (Sandcat)
CapriCORN
Comprehensive Analysis of Pathogens, Resistomes, and Inflammatory-markers in the Cornea
RECORDATI MT8
Efficacy, Safety and Pharmacokinetics of 3 Doses of REC 0/0559 Eye Drops (MT8) for the Treatment of Stage 2 (Moderate) and 3 (Severe) Neurotrophic Keratitis in Adult Patients
IMVT TED
A Phase 3, Multi-center, Randomized, Quadruple-masked, Placebo-controlled Study of Batoclimab for the Treatment of Participants with Active Thyroid Eye Disease (TED)
New nanoparticles aid sepsis treatment in mice
Tens of millions of people worldwide are affected by diseases like macular degeneration or have had accidents that permanently damage the light-sensitive photoreceptors within their retinas that enable vision.
Micro-molded ‘ice cube tray’ scaffold is next step in returning sight to injured retinas
In new research published today, UW–Madison researchers reported a new nanoparticle-based treatment for sepsis that delivers anti-inflammatory molecules and antibiotics.